Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2416PDF: 675HTML: 2266 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2076PDF: 973HTML: 1961Characteristic of study group: 159 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1172PDF: 625HTML: 185 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
1902PDF: 1822HTML: 117 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2298PDF: 723HTML: 1708 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1495PDF: 765HTML: 942 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3060PDF: 1159HTML: 8057 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1294PDF: 459HTML: 207 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1853PDF: 1447HTML: 334 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1672PDF: 664HTML: 2067Untitled: 155Untitled: 128Untitled: 132Untitled: 129Untitled: 133Untitled: 151Untitled: 145 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1497PDF: 1145HTML: 205 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
1923PDF: 933HTML: 4024Cover Letter: 193Figure 1: 188Figure 2: 194Table 1: 168 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7058PDF: 2322HTML: 1652Table 1.: 159Table 2.: 177Table 3.: 158Table 4.: 151 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
805PDF: 957Suppl. Files: 536HTML: 60 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3479PDF: 1555HTML: 11255Figures Haase: 164 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3354Suppl. Files: 947PDF: 969Html: 86 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
828PDF: 543HTML: 2167Cover Letter: 150 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3409PDF: 799HTML: 6681 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4044PDF: 1305HTML: 2012 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4042PDF: 1404HTML: 1510Untitled: 192 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2233PDF: 1282HTML: 1932 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3349PDF: 988HTML: 859 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3613PDF: 1347HTML: 8459 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1538PDF: 1020HTML: 10671Untitled: 143 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1786PDF: 706HTML: 3091







